Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

BACKGROUND: Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data from patients with rheumatoid arthritis revealed that dose tapering combined with tight control of disease activity is successful....

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Dermatol
Main Authors: Atalay, Selma, van den Reek, Juul M. P. A., van Vugt, Lieke J., Otero, Marisol E., van de Kerkhof, Peter C. M., den Broeder, Alfons A., Kievit, Wietske, de Jong, Elke M. G. J.
格式: Artigo
語言:Inglês
出版: BioMed Central 2017
主題:
Study Protocol
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422943/
https://ncbi.nlm.nih.gov/pubmed/28482858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12895-017-0057-6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍